Skip to content
← Back to this collection

PUBLICATIONS · 14551340

Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2003 Nov 6
First author
Burstein HJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2003 Nov 6;349(19):1793-802. doi: 10.1056/NEJMoa032312.
    note
    Source null
    related pmid
    14551341
    relationship
    Comment on
  2. citation
    N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
    note
    Source null
    related pmid
    14971057
    relationship
    Comment in
  3. citation
    N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
    note
    Source null
    related pmid
    14971059
    relationship
    Comment in

Authors and identifiers

  1. name
    Burstein HJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burstein HJ
    type
    Author
bibliography ids
  1. nci-bib-6e58bbe4bc66e7137591bc69
book metadata
content sha256
55b21e9c028f1dee8dac9805fcec0b67bf78fa8e19eb02ecd9b088d50c8efb43
document type
citation
dois
  1. 10.1056/NEJMe038174
electronic publication date
display
2003 Oct 9
precision
day
year
2003
evidence scope
bibliographic_metadata_only
id
pubmed:14551340
immutable id
pubmed:14551340@55b21e9c028f1dee8dac9805fcec0b67bf78fa8e19eb02ecd9b088d50c8efb43
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
19
name
The New England journal of medicine
nlm unique id
0255562
pages
1857-9
volume
349
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2003 Nov 6;349(19):1793-802. doi: 10.1056/NEJMoa032312.
    note
    Source null
    related pmid
    14551341
    relationship
    Comment on
  2. citation
    N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
    note
    Source null
    related pmid
    14971057
    relationship
    Comment in
  3. citation
    N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30.
    note
    Source null
    related pmid
    14971059
    relationship
    Comment in
outcomes validated
false
pmid
14551340
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
5c88816c9a61d33bbd86ef2478d9d506a610eedbbbf1f1055574c94843275e0c
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Nov 6
precision
day
year
2003
publication types
  1. Editorial
  2. Comment
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/14551340/
title
Beyond tamoxifen--extending endocrine treatment for early-stage breast cancer.

Preserved source evidence · Not medical advice